Contact Us Home

POC Calendar >

POC Groups >

POCC of the Year >

POC Vendors >

POC Tests >

POC Procedures >

News Archive

Have a new product release you want to publish on Point of Click here

  • Radiometer’s ABL90 analyzer 510(k) cleared More >

  • Roche Receives FDA Clearance for CoaguChek XS Pro More >

  • MAS to Integrate ITC’s AVOXimeter 4000 and AVOXimeter 1000E to RALS®-Plus Click here

  • Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Click here

  • Radiometer Announces Limited Launch of ABL® Series Blood Gas Analyzer Module to RALS®-Plus Click here

  • Blood Glucose Benchmarking Results in U.S. Hospitals for 2008 Announced Click here

  • Wireless Monitoring of Blood Glucose  More >

  • HemoCue granted FDA waiver for point-of-care test HemoCue, a wholly owned subsidiary of Quest Diagnostics, has announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the FDA.

  • For glucoses, tight theory a tough practice More >

Last updated: 10/18/2010 Questions or corrections: My Point of© 2008 Medical Automation Systems, Inc. Legal Notice.
This web site is made possible in total by the support of Medical Automation Systems.

Back to top